(Total Views: 202)
Posted On: 04/01/2020 3:19:33 PM
Post# of 112
NetworkNewsBreaks – MCTC Holdings, Inc. (MCTC) Announces Full Integration of Lelantos Biotech’s Unique Technologies
MCTC Holdings (OTC: MCTC), a cannabinoid and hemp extract science forward company developing infusion and delivery technologies, this morning announced the full integration of Lelantos Biotech into MCTC. The company also provided an operational and product introduction update. MCTC announced the acquisition of Lelantos Biotech, Inc. in mid-February. Lelantos Biotech had previously been involved in various areas of cannabinoid and hemp infusion research and had closely collaborated with MCTC in relation to the filing of several patents in numerous hemp extract and cannabinoid delivery technologies. All the developments generated from this collaboration have been assigned to MCTC, and the rights to all six patent pending technologies belong to MCTC. Among other highlights, the update also included further information regarding the integration of the Lelantos technologies, the company’s latest Hemp You Can Feel(TM) products, and the completion of phase one of its Project Varin. “We have now integrated the Lelantos technologies and trade secrets into MCTC Holdings,” MCTC Holdings CEO Arman Tabatabaei stated in the news release. “The manner in which Lelantos was acquired was particularly shareholder-friendly with the owners agreeing to take long term notes in exchange for all of the IP and all rights to the technology. We are now actively integrating these unique and patent pending technologies into several products to be marketed under the Hemp You Can Feel(TM) brand. In all, Lelantos has provided the core technologies allowing us to now have six patents pending. We plan an active announcement and product introduction calendar as we continue to create new products based on these innovations.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
MCTC Holdings (OTC: MCTC), a cannabinoid and hemp extract science forward company developing infusion and delivery technologies, this morning announced the full integration of Lelantos Biotech into MCTC. The company also provided an operational and product introduction update. MCTC announced the acquisition of Lelantos Biotech, Inc. in mid-February. Lelantos Biotech had previously been involved in various areas of cannabinoid and hemp infusion research and had closely collaborated with MCTC in relation to the filing of several patents in numerous hemp extract and cannabinoid delivery technologies. All the developments generated from this collaboration have been assigned to MCTC, and the rights to all six patent pending technologies belong to MCTC. Among other highlights, the update also included further information regarding the integration of the Lelantos technologies, the company’s latest Hemp You Can Feel(TM) products, and the completion of phase one of its Project Varin. “We have now integrated the Lelantos technologies and trade secrets into MCTC Holdings,” MCTC Holdings CEO Arman Tabatabaei stated in the news release. “The manner in which Lelantos was acquired was particularly shareholder-friendly with the owners agreeing to take long term notes in exchange for all of the IP and all rights to the technology. We are now actively integrating these unique and patent pending technologies into several products to be marketed under the Hemp You Can Feel(TM) brand. In all, Lelantos has provided the core technologies allowing us to now have six patents pending. We plan an active announcement and product introduction calendar as we continue to create new products based on these innovations.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)
